RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis AI Analysis of FBIO
Powered by GPT-4o
Stock Analysis
Risk Assessment
Trading Strategy
PDF

Evaluation of Fortress Biotech stock downgraded after the last trading session
(Updated on Sep 19, 2024)

Sell candidate since Sep 19, 2024

The Fortress Biotech stock price fell by -4.17% on the last day (Thursday, 19th Sep 2024) from $1.92 to $1.84. During the last trading day the stock fluctuated 9.89% from a day low at $1.82 to a day high of $2.00. The price has fallen in 6 of the last 10 days and is down by -0.54% for this period. Volume has increased on the last day by 109 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 355 thousand shares were bought and sold for approximately $653.74 thousand.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.77 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 3.24% during the next 3 months and, with a 90% probability hold a price between $1.83 and $2.75 at the end of this 3-month period.

FBIO Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, August 07, 2024, and so far it has risen 6.36%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Fortress Biotech stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.88 and $1.91. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Fortress Biotech gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Fortress Biotech stock

Fortress Biotech finds support from accumulated volume at $1.83 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.180 between high and low, or 9.89%. For the last week, the stock has had daily average volatility of 6.63%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (FBIO) For The Upcoming Trading Day Of Friday 20th

For the upcoming trading day on Friday, 20th we expect Fortress Biotech to open at $1.89, and during the day (based on 14 day Average True Range), to move between $1.71 and $1.97, which gives a possible trading interval of +/-$0.128 (+/-6.95%) up or down from last closing price. If Fortress Biotech takes out the full calculated possible swing range there will be an estimated 13.91% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.83 (0.54%) than the resistance at $1.97 (7.07%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Fortress Biotech stock A Buy?

The Fortress Biotech stock holds several negative signals and despite the positive trend, we believe Fortress Biotech will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -2.278 Sell Candidate Downgraded

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Predicted Fair Opening Price

Predicted fair opening price on September 20, 2024 - $1.89 ( 2.54%). The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for FBIO

Fibonacci Support & Resistance Levels

Level Price
R3 2.07 12.32%
R2 2.00 8.58%
R1 1.96 6.27%
Price 1.84
S1 1.82 -1.20%
S2 1.78 -3.51%
S3 1.71 -7.25%

Accumulated Volume Support & Resistance Levels

Level Price
R3 2.25 22.28%
R2 2.09 13.59%
R1 1.97 7.07%
Price 1.84
S1 1.83 -0.543%
S2 1.77 -3.80%
S3 1.76 -4.35%

FAQ

What is the symbol for Fortress Biotech Stock and on which exchange is it traded?
The symbol for Fortress Biotech is FBIO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Fortress Biotech Stock?
The Fortress Biotech stock holds several negative signals and despite the positive trend, we believe Fortress Biotech will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Fortress Biotech Stock?
Fortress Biotech Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Fortress Biotech Stock.

What's the current price of Fortress Biotech Stock?
As of the end of day on the Sep 19, 2024, the price of an Fortress Biotech (FBIO) share was $1.84.

What is the 52-week high and low for Fortress Biotech Stock?
The 52-week high for Fortress Biotech Stock is $4.64 and the 52-week low is $0.281.

What is the market capitalization of Fortress Biotech Stock?
As of the Sep 19, 2024, the market capitalization of Fortress Biotech is 43.803M.

When is the next earnings date for Fortress Biotech?
The upcoming earnings date for Fortress Biotech is Nov 12, 2024.
Click to get the best stock tips daily for free!

About Fortress Biotech

Fortress Biotech Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules... FBIO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT